{
    "Clinical Trial ID": "NCT01310075",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Arm 1",
        "Surgimend",
        "INTERVENTION 2: ",
        "  Arm 2",
        "Alloderm"
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Patients undergoing immediate tissue expander reconstruction following mastectomy by any of the surgeon co-investigators are eligible for the study.",
        "  Patients 18 years of age or older are eligible for the study.",
        "  Patients undergoing skin-sparing mastectomy utilizing bioprosthetic mesh are eligible for the study.",
        "  Patients who have not undergone autologous tissue breast reconstruction and intend to undergo implant only breast reconstruction.",
        "  Patients who intend to remain under the MDACC surgeon's care until completion of the reconstruction.",
        "Exclusion Criteria:",
        "  Patients with prior radiation to the breast/chest wall of the ipsilateral breast .",
        "  Patients who cannot be effectively reconstructed without the use of bioprosthetic mesh.",
        "  Patients who are current smokers.",
        "  Patients requiring additional intra-operative skin resections of greater than 1cm beyond the skin edge as a result of mastectomy flap devascularization.",
        "  Patients who have a history of breast tissue expander or implant placement."
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Number of Participants With Complications After Tissue Expander Replacement With Implant",
        "  [Not Specified]",
        "  Time frame: through study completion, an average of 1 year",
        "Results 1: ",
        "  Arm/Group Title: Arm 1",
        "  Arm/Group Description: Surgimend",
        "  Overall Number of Participants Analyzed: 31",
        "  Measure Type: Number",
        "  Unit of Measure: participants  10",
        "Results 2: ",
        "  Arm/Group Title: Arm 2",
        "  Arm/Group Description: Alloderm",
        "  Overall Number of Participants Analyzed: 35",
        "  Measure Type: Number",
        "  Unit of Measure: participants  10"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 3/31 (9.68%)",
        "  Pain 1/31 (3.23%)",
        "  Infection 1/31 (3.23%)",
        "  Hypophosphatemia 0/31 (0.00%)",
        "  Muscle spasms 0/31 (0.00%)",
        "  Delayed wound healing 1/31 (3.23%)",
        "Adverse Events 2:",
        "  Total: 2/35 (5.71%)",
        "  Pain 0/35 (0.00%)",
        "  Infection 0/35 (0.00%)",
        "  Hypophosphatemia 1/35 (2.86%)",
        "  Muscle spasms 1/35 (2.86%)",
        "  Delayed wound healing 0/35 (0.00%)"
    ]
}